Sara Op de Beeck1, Marijke Dieltjens2, Annelies E Verbruggen3, Anneclaire V Vroegop3, Kristien Wouters4, Evert Hamans5, Marc Willemen6, Johan Verbraecken7, Wilfried A De Backer5, Paul H Van de Heyning1, Marc J Braem8, Olivier M Vanderveken1. 1. Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; ENT, Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium; Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital, Edegem, Belgium. 2. Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; ENT, Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium; Special Dentistry Care, Antwerp University Hospital, Edegem, Belgium. 3. Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; ENT, Head and Neck Surgery, Antwerp University Hospital, Edegem, Belgium. 4. Clinical Trial Centre (CTC), CRC Antwerp, Antwerp University Hospital, Edegem, Antwerp, Belgium. 5. Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium. 6. Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital, Edegem, Belgium. 7. Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital, Edegem, Belgium; Department of Pulmonology, Antwerp University Hospital, Edegem, Antwerp, Belgium. 8. Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium; Special Dentistry Care, Antwerp University Hospital, Edegem, Belgium.
Abstract
STUDY OBJECTIVES: Mandibular advancement device (MAD) outcome varies between patients. We hypothesized that upper airway collapse sites, patterns, and degrees assessed during baseline drug-induced sleep endoscopy (DISE) affect MAD outcome. METHODS: One hundred patients with obstructive sleep apnea (OSA) were included and underwent baseline type 1 polysomnography. MAD was fitted intraorally at fixed 75% maximal protrusion. A total of 72 patients completed 3-month follow-up polysomnography and baseline DISE. Response was defined as apnea-hypopnea index (AHI) reduction ≥ 50%, deterioration as AHI increases during MAD treatment compared to baseline. RESULTS: Adjusting for baseline AHI and body mass index, patients with tongue base collapse showed 3.69 higher odds (1.27-10.73; P = .0128) for response. Complete concentric collapse at the level of the palate (5.32 [1.21-23.28]; P = .0234) and complete laterolateral oropharyngeal collapse (6.62 [1.14-38.34]; P = .0330) related to deterioration. Results for tongue base collapse and complete concentric collapse at the level of the palate were confirmed in the moderate to severe OSA subgroup. Applying these results to this selected subgroup increased response rate with 54% and decreased deterioration rate with 53%. These results were confirmed using other response and deterioration definitions. CONCLUSIONS: Three baseline DISE phenotypes identified during drug-induced sleep were significantly related to MAD treatment outcome: one beneficial, tongue base collapse, and two adverse, complete concentric collapse at the level of the palate and complete laterolateral oropharyngeal collapse. If confirmed in future prospective studies, these results could guide patient selection for MAD outcome. CLINICAL TRIAL REGISTRATION: This prospective clinical trial (PROMAD) was registered on Clinicaltrials.gov with identifier: NCT01532050. CITATION: Op de Beeck S, Dieltjens M, Verbruggen AE, Vroegop AV, Wouters K, Hamans E, Willemen M, Verbraecken J, De Backer WA, Van de Heyning PH, Braem MJ, Vanderveken OM. Phenotypic labelling using drug-induced sleep endoscopy improves patient selection for mandibular advancement device outcome: a prospective study. J Clin Sleep Med. 2019;15(8):1089-1099.
STUDY OBJECTIVES: Mandibular advancement device (MAD) outcome varies between patients. We hypothesized that upper airway collapse sites, patterns, and degrees assessed during baseline drug-induced sleep endoscopy (DISE) affect MAD outcome. METHODS: One hundred patients with obstructive sleep apnea (OSA) were included and underwent baseline type 1 polysomnography. MAD was fitted intraorally at fixed 75% maximal protrusion. A total of 72 patients completed 3-month follow-up polysomnography and baseline DISE. Response was defined as apnea-hypopnea index (AHI) reduction ≥ 50%, deterioration as AHI increases during MAD treatment compared to baseline. RESULTS: Adjusting for baseline AHI and body mass index, patients with tongue base collapse showed 3.69 higher odds (1.27-10.73; P = .0128) for response. Complete concentric collapse at the level of the palate (5.32 [1.21-23.28]; P = .0234) and complete laterolateral oropharyngeal collapse (6.62 [1.14-38.34]; P = .0330) related to deterioration. Results for tongue base collapse and complete concentric collapse at the level of the palate were confirmed in the moderate to severe OSA subgroup. Applying these results to this selected subgroup increased response rate with 54% and decreased deterioration rate with 53%. These results were confirmed using other response and deterioration definitions. CONCLUSIONS: Three baseline DISE phenotypes identified during drug-induced sleep were significantly related to MAD treatment outcome: one beneficial, tongue base collapse, and two adverse, complete concentric collapse at the level of the palate and complete laterolateral oropharyngeal collapse. If confirmed in future prospective studies, these results could guide patient selection for MAD outcome. CLINICAL TRIAL REGISTRATION: This prospective clinical trial (PROMAD) was registered on Clinicaltrials.gov with identifier: NCT01532050. CITATION: Op de Beeck S, Dieltjens M, Verbruggen AE, Vroegop AV, Wouters K, Hamans E, Willemen M, Verbraecken J, De Backer WA, Van de Heyning PH, Braem MJ, Vanderveken OM. Phenotypic labelling using drug-induced sleep endoscopy improves patient selection for mandibular advancement device outcome: a prospective study. J Clin Sleep Med. 2019;15(8):1089-1099.
Authors: Olivier M Vanderveken; Annick Devolder; Marie Marklund; An N Boudewyns; Marc J Braem; Walter Okkerse; Johan A Verbraecken; Karl A Franklin; Wilfried A De Backer; Paul H Van de Heyning Journal: Am J Respir Crit Care Med Date: 2007-08-02 Impact factor: 21.405
Authors: A S L Chan; R W W Lee; V K Srinivasan; M A Darendeliler; R R Grunstein; P A Cistulli Journal: Eur Respir J Date: 2009-09-24 Impact factor: 16.671
Authors: Andrew S L Chan; Kate Sutherland; Richard J Schwab; Biao Zeng; Peter Petocz; Richard W W Lee; M Ali Darendeliler; Peter A Cistulli Journal: Thorax Date: 2010-08 Impact factor: 9.139
Authors: Eric J Kezirian; David P White; Atul Malhotra; Wendy Ma; Charles E McCulloch; Andrew N Goldberg Journal: Arch Otolaryngol Head Neck Surg Date: 2010-04
Authors: W J Randerath; J Verbraecken; S Andreas; G Bettega; A Boudewyns; E Hamans; F Jalbert; J R Paoli; B Sanner; I Smith; B A Stuck; L Lacassagne; M Marklund; J T Maurer; J L Pepin; A Valipour; T Verse; I Fietze Journal: Eur Respir J Date: 2011-03-15 Impact factor: 16.671
Authors: Lawrence J Epstein; David Kristo; Patrick J Strollo; Norman Friedman; Atul Malhotra; Susheel P Patil; Kannan Ramar; Robert Rogers; Richard J Schwab; Edward M Weaver; Michael D Weinstein Journal: J Clin Sleep Med Date: 2009-06-15 Impact factor: 4.062
Authors: F Gagnadoux; B Fleury; B Vielle; B Pételle; N Meslier; X L N'Guyen; W Trzepizur; J L Racineux Journal: Eur Respir J Date: 2009-03-26 Impact factor: 16.671
Authors: Maite Barbero; Carlos Flores-Mir; Juan Calvo Blanco; Valentin Cabriada Nuño; Joan Brunso Casellas; Jose Luis Calvo Girado; Julio Alvarez Amezaga; Felix De Carlos Journal: J Clin Sleep Med Date: 2020-10-15 Impact factor: 4.062
Authors: Patty E Vonk; Julia A M Uniken Venema; Aarnoud Hoekema; Madeline J L Ravesloot; Johanna A van de Velde-Muusers; Nico de Vries Journal: J Clin Sleep Med Date: 2020-07-15 Impact factor: 4.062
Authors: Erin V Mosca; Sabina Bruehlmann; Shaelynn M Zouboules; Alexandra E Chiew; Curtis Westersund; Dillon A Hambrook; Seyed A Zareian Jahromi; Joshua Grosse; Zbigniew L Topor; Shouresh Charkhandeh; John E Remmers Journal: J Clin Sleep Med Date: 2022-03-01 Impact factor: 4.062
Authors: Zhengfei Huang; Pien F N Bosschieter; Ghizlane Aarab; Maurits K A van Selms; Joost W Vanhommerig; Antonius A J Hilgevoord; Frank Lobbezoo; Nico de Vries Journal: J Clin Sleep Med Date: 2022-09-01 Impact factor: 4.324
Authors: Eli Van de Perck; Sara Op de Beeck; Marijke Dieltjens; Anneclaire V Vroegop; Annelies E Verbruggen; Marc Willemen; Johan Verbraecken; Paul H Van de Heyning; Marc J Braem; Olivier M Vanderveken Journal: J Clin Sleep Med Date: 2020-07-15 Impact factor: 4.062
Authors: Daniel Vena; Ali Azarbarzin; Melania Marques; Sara Op de Beeck; Olivier M Vanderveken; Bradley A Edwards; Nicole Calianese; Lauren B Hess; Reza Radmand; Garun S Hamilton; Simon A Joosten; Luigi Taranto-Montemurro; Sang-Wook Kim; Johan Verbraecken; Marc Braem; David P White; Scott A Sands; Andrew Wellman Journal: Sleep Date: 2020-07-13 Impact factor: 5.849
Authors: Sara Op de Beeck; Marijke Dieltjens; Ali Azarbarzin; Marc Willemen; Johan Verbraecken; Marc J Braem; Andrew Wellman; Scott A Sands; Olivier M Vanderveken Journal: Ann Am Thorac Soc Date: 2021-03
Authors: Ning Zhou; Jean-Pierre T F Ho; Nico de Vries; Pien F N Bosschieter; Madeline J L Ravesloot; Jan de Lange Journal: J Clin Sleep Med Date: 2022-04-01 Impact factor: 4.062
Authors: Sara Op de Beeck; Andrew Wellman; Marijke Dieltjens; Kingman P Strohl; Marc Willemen; Paul H Van de Heyning; Johan A Verbraecken; Olivier M Vanderveken; Scott A Sands Journal: Am J Respir Crit Care Med Date: 2021-03-15 Impact factor: 21.405
Authors: Crystal Sj Cheong; Weiqiang Loke; Mark Kim Thye Thong; Song Tar Toh; Chi-Hang Lee Journal: Clin Exp Otorhinolaryngol Date: 2020-10-16 Impact factor: 3.372